CTSO CIK: 1175151

Cytosorbents Corp

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY24
FY24
FY24
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
20.0
FY24:
22.0
FY24:
16.6
FY24:
21.6
FY25:
20.6
(positive)
Change from FY24 to FY25
millions USD
FY24:
27.1
FY24:
31.5
FY24:
31.2
FY24:
25.8
FY25:
23.5
Total assets
Change from FY24 to FY25
millions USD
FY24:
47.1
FY24:
53.4
FY24:
47.8
FY24:
47.4
FY25:
44.2

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
12.7
FY24:
9.64
FY24:
8.28
FY24:
9.83
FY25:
9.71
(negative)
Change from FY24 to FY25
millions USD
FY24:
14.7
FY24:
26.4
FY24:
26.4
FY24:
26.4
FY25:
28.6
(positive)
Change from FY24 to FY25
millions USD
FY24:
19.6
FY24:
17.4
FY24:
13.1
FY24:
11.1
FY25:
5.90
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY24:
47.1
FY24:
53.4
FY24:
47.8
FY24:
47.4
FY25:
44.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data